(DNUT) Krispy Kreme - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US50101L1061
DNUT: Doughnuts, Cookies, Ice Cream, Brownies
Krispy Kreme, Inc. (NASDAQ:DNUT) is a global doughnut and sweet treats company with operations spanning the United States, the United Kingdom, Ireland, Australia, New Zealand, Mexico, Canada, Japan, and other international markets. The company operates through three distinct business segments: U.S., International, and Market Development. This structure allows Krispy Kreme to manage its established markets while also focusing on expansion into new regions.
The company is known for its iconic glazed doughnuts, which are produced fresh daily and distributed through a variety of channels. These include hot light theater locations, fresh shops, branded cabinets in grocery and convenience stores, quick-service restaurants, and e-commerce platforms. In addition to its core doughnut business, Krispy Kreme has diversified its offerings to include cookies under the Insomnia Cookies brand, cookie cakes, ice cream, cookie-wiches, and brownies. This diversification strategy aims to capture a broader share of the sweet treats market. The company also operates both company-owned shops and franchise locations, balancing control over the brand experience with the scalability of franchising.
Formerly known as Krispy Kreme Doughnuts, Inc., the company rebranded as Krispy Kreme, Inc. in May 2021, reflecting its expanded product portfolio beyond traditional doughnuts. Founded in 1937 and headquartered in Charlotte, North Carolina, Krispy Kreme has built a strong brand reputation over nearly a century. As of recent filings, the company has a market capitalization of approximately $1.45 billion, with a price-to-earnings (P/E) ratio of 53.44. Its price-to-book (P/B) ratio is 1.23, and the price-to-sales (P/S) ratio stands at 0.85. These metrics provide insight into the companys valuation for investors and fund managers evaluating its stock.
For more information, visit their website at https://www.krispykreme.com.
Additional Sources for DNUT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DNUT Stock Overview
Market Cap in USD | 828m |
Sector | Consumer Defensive |
Industry | Grocery Stores |
GiC Sub-Industry | Restaurants |
IPO / Inception | 2021-07-01 |
DNUT Stock Ratings
Growth 5y | -73.3% |
Fundamental | -8.87% |
Dividend | 51.5% |
Rel. Strength | -70.5 |
Analysts | 3.91/5 |
Fair Price Momentum | 3.74 USD |
Fair Price DCF | - |
DNUT Dividends
Dividend Yield 12m | 2.23% |
Yield on Cost 5y | 0.87% |
Annual Growth 5y | 41.42% |
Payout Consistency | 98.0% |
DNUT Growth Ratios
Growth Correlation 3m | -87.6% |
Growth Correlation 12m | -76.7% |
Growth Correlation 5y | -66.5% |
CAGR 5y | -31.24% |
CAGR/Max DD 5y | -0.41 |
Sharpe Ratio 12m | -2.03 |
Alpha | -78.15 |
Beta | 1.401 |
Volatility | 45.12% |
Current Volume | 6501.9k |
Average Volume 20d | 2821k |
As of April 04, 2025, the stock is trading at USD 4.95 with a total of 6,501,916 shares traded.
Over the past week, the price has changed by -8.67%, over one month by -18.99%, over three months by -48.92% and over the past year by -66.37%.
Neither. Based on ValueRay Fundamental Analyses, Krispy Kreme is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -8.87 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DNUT as of April 2025 is 3.74. This means that DNUT is currently overvalued and has a potential downside of -24.44%.
Krispy Kreme has received a consensus analysts rating of 3.91. Therefor, it is recommend to buy DNUT.
- Strong Buy: 3
- Buy: 4
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, DNUT Krispy Kreme will be worth about 4.1 in April 2026. The stock is currently trading at 4.95. This means that the stock has a potential downside of -17.58%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 11.4 | 130.9% |
Analysts Target Price | 15.3 | 209.5% |
ValueRay Target Price | 4.1 | -17.6% |